Michael J. LaBarre
2020
Compensation breakdown
| Non-Equity Incentive Plan | $220,163 |
|---|---|
| Option Awards | $650,007 |
| Salary | $475,000 |
| Stock Awards | $650,009 |
| Other | $15,018 |
| Total | $2,010,197 |
LaBarre received $650K in stock awards, accounting for 32% of the total pay in 2020.
LaBarre also received $220.2K in non-equity incentive plan, $650K in option awards, $475K in salary and $15K in other compensation.
Rankings
In 2020, Michael J. LaBarre's compensation ranked 5,486th out of 13,090 executives tracked by ExecPay. In other words, LaBarre earned more than 58.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,486 out of 13,090 | 58th |
Division Manufacturing | 2,257 out of 5,621 | 60th |
Major group Chemicals And Allied Products | 900 out of 2,254 | 60th |
Industry group Drugs | 777 out of 1,954 | 60th |
Industry Biological Products, Except Diagnostic Substances | 186 out of 411 | 55th |
Pay ratio
| Michael J. LaBarre's Pay | $2,010,197 |
|---|---|
| Median Employee's Pay | $223,441 |
| Pay Ratio | 9to 1 |
In 2020, the annual total compensation of Michael J. LaBarre was $2,010,197.
The annual total compensation of the median employee at Halozyme Therapeutics was $223,441.
The ratio of Michael J. LaBarre's pay to the pay of median employee was therefore 9 to one.
LaBarre's colleagues
We found four more compensation records of executives who worked with Michael J. LaBarre at Halozyme Therapeutics in 2020.